论文部分内容阅读
49岁男性,CT提示右肝巨大肿块,临床诊断为肝细胞肝癌,国际常用的肝癌临床分期系统(BCLC)“宣判”该患者为晚期(C期),根据BCLC建议应采用分子靶向药物治疗。也就是说,这是一个被宣告无法手术治疗的病例。但药物治疗中位生存期可能不会超过10个月,不治疗可能仅1-4个月。然而,这位晚期肿瘤病人却获得了根治性切除!他目前已经无瘤生存了2年5个月,一般情况良好,正常工作生活。为他实施手术的,
49-year-old man, CT showed a large mass of the right liver, clinical diagnosis of hepatocellular carcinoma, the international clinical staging system of liver cancer (BCLC) “the sentencing ” the patient is advanced (C stage), BCLC recommendations should be based on molecular targeting medical treatement. That is to say, this is a reported case of no surgical treatment. Median survival may not exceed 10 months for drug treatment, or only 1-4 months for no treatment. However, the advanced cancer patient has undergone radical resection! He has now survived 2 years and 5 months without any tumor, and he is generally in good condition and working and living normally. For his surgery